复方异丙托溴铵溶液和布地奈德混悬液联合雾化吸入治疗毛细支气管炎疗效观察  

作　　者：邝朝锋[1] 欧少阳[1] 邹春山[1] 

机构地区：[1]广东揭阳市人民医院儿三科,522000

出　　处：《中国社区医师（医学专业）》2012年第17期138-139,共2页

摘　　要：目的:探讨采用复方异丙托溴铵溶液和布地奈德混悬液联合雾化吸入治疗毛细支气管炎的临床疗效。方法:将77例患儿(年龄30天～12个月)按家属自愿原则分为雾化组和对照组,给对照组进行毛细支气管炎的综合治疗,雾化组在对照组的基础上采用复方异丙托溴铵溶液和布地奈德混悬液联合雾化吸入治疗,比较两组的临床症状和体征的消失时间和住院时间,比较两组的疗效。结果:雾化组的临床症状、体征消失时间及住院时间均比对照组早(P<0.01);疗效对比中,雾化组的治愈率95%,对照组76%,雾化组明显优于对照组(P<0.05)。结论:复方异丙托溴铵溶液和布地奈德混悬液联合雾化吸入治疗毛细支气管炎疗效显著。Objective：To study the clinical effectiveness for the treatment of bronchiolitis by combined atomization inhalation of compound ipratropium bromide solution and budesonide suspension. Methods ： 77 pediatric patients（ age 30 days to 12 months）were divided into the atomization group and control group at the permission from their families. The control group were given the comprehensive treatment for bronchiolitis and the atomization group were given the combined atomization inhalation of compound ipratropium bromide solution and budesonide suspension in addition to the comprehensive treatment same to that of the control group. Compare the two groups in terms of symptom and sign disappearing time and the hospitalization period as well as the therapeutic effectiveness. Result： the symptom and sign disappearing time and the hospitalization period of the atomization group are shorter than the control group （ P 〈 0.01 ） ;as to the therapeutic effectiveness comparison, the atomization group had the cure rates of 95% ,and the control group had 76% , so that the atomization group is significantly better than the control group （ P 〈 0.05 ）. Conclusion：The combined atomization inhalation of compound ipratropium bromide solution and budesonide suspension in the treatment of bronchiolitis has significant effectiveness and is worthy of promotion.

关 键 词：雾化吸入 复方异丙托溴铵溶液 布地奈德混悬液 毛细支气管炎 

分 类 号：R725.622.5[医药卫生—儿科]